Mark A Meltz's Net Worth
$2.31 Million
Who is Mark A Meltz?
Mark A Meltz has an estimated net worth of $2.31 Million. This is based on reported shares across multiple companies, which include Kinnate Biopharma Inc., and Audentes Therapeutics, Inc..
SEC CIK
Mark A Meltz's CIK is 0001771329
Past Insider Trading and Trends
2019 was Mark A Meltz's most active year for acquiring shares with 2 total transactions. Mark A Meltz's most active month to acquire stocks was the month of January. 2023 was Mark A Meltz's most active year for disposing of shares, totalling 4 transactions. Mark A Meltz's most active month to dispose stocks was the month of November. 2023 saw Mark A Meltz paying a total of $0.00 for 215,000 shares, this is the most they've acquired in one year. In 2020 Mark A Meltz cashed out on 136,705 shares for a total of $1,962,300.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.33
COO GENERAL COUNSEL SECRETARY
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -27.58K |
—
|
—
|
0
|
Apr 3
| |||
Form 4
| -1.98% | -558.00 |
$2.59 | -$1,445.22 | 27.58K |
Mar 1
| |||
Form 4
| -1.89% | -541.00 |
$2.25 | -$1,217.25 | 28.14K |
Dec 1
| |||
Form 4
| -1.85% | -541.00 |
$2.35 | -$1,271.35 | 28.68K |
Sep 1
| |||
Form 4
| -1.82% | -541.00 |
$4.30 | -$2,326.30 | 29.22K |
Jun 1
| |||
Form 4
| -2.28% | -638.00 |
$5.21 | -$3,323.98 | 27.29K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -1.90% | -541.00 |
$7.75 | -$4,192.75 | 27.92K |
Dec 1
| |||
Form 4
| +721.50% | 25K |
—
|
—
| 28.46K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Audentes Therapeutics, Inc. No price found
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -32.70K |
$60.00 | -$1,962,300.00 |
0
|
Jan 15
| |||
Form 4
| -12.40% | -4.63K |
$59.37 | -$274,764.36 | 32.7K |
Dec 12
| |||
Form 4
|
∞
| 37.33K |
—
|
—
| 37.33K |
Mar 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||